We previously showed that SNPs can act as biomarkers in AML [46,47], and we identified some BSG and MCT1 variants that were associated with survival in multiple myeloma patients; most importantly, BSG allele rs4919859 C was associated with worse MM progression-free survival [25]. The gene discussed is SLC16A1; the disease is AL amyloidosis.